Rami Komrokji: Imetelstat approved for MDS patients

Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center, shared a post on X:       .

“I am so honored to be part of this journey as a senior clinical investigator and having presented the data to the ODAC (Oncologic Drugs Advisory Committee) FDA committee to get Imetelstat approved to hopefully help many of our MDS (Myelodysplastic syndromes) patients.”

Read Further.
Source: Rami Komrokji/X